After separately proving the ability of NPTyr-C9AP to enhance T-cell recruitment and activation by expressing CXCL9 and αPD-L1, we designed a transwell migration and cytotoxicity assay to detect the synergistic effects of NPTyr-C9AP on recruiting and activating T cells to kill melanoma cells. This evidence concerns the gene CXCL9 and melanoma.